Venous Leg Ulcer Solutions

Getting your patients back on their feet

Venous Leg Ulcer Solutions

Impact of venous leg ulcers

  • Venous leg ulcers (VLUs) are the most common type of lower extremity wound, afflicting approximately 1% of the western population during their lifetime. VLUs also represent a significant burden for patients and healthcare systems.¹


Infographic showing: Annual cost to treat VLUS is $14.9B, 55% of healed VLUs occour in first 12 months of closure. 38% of patients experience >10 VLU episodes in thier lifetime.
Solutions for Managing Chronic Edema and VLUs**
Solutions for Managing Chronic Edema and VLUs
DOWNLOAD THE BROCHURE (PDF, 1.20 MB)

Best Practices for VLU wound management

Select one for each step

Click on each hotspot to view more information

Step 1 Protect Skin

Skin damage is often associated with VLUs. Adverse skin changes can also be noted when dressings are unable to manage the volume of drainage or are not changed often enough.

At-risk or damaged skin protection
Step 2: Manage biofilm/bioburden

Biofilm is prevalent in 90% of all chronic wounds,⁵,⁶ including VLUs. The presence of biofilm on a chronic wound delays wound healing by perpetuating the inflammatory phase. Anti-biofilm strategies should be implemented at the start of wound management.

BlastX™ Antimicrobial Wound Gel
KERRACEL™ Ag Gelling Fiber Silver Dressing
SILVERCEL™ Antimicrobial Alginate Dressing
Step 3: Optimize wound environment

VLUs are typically shallow, full-thickness wounds with moderate to high exudate levels. Effective exudate management can help reduce time to heal, dressing change frequency and nursing input, thereby optimizing health care efficiency.⁷

Provide collagen
Step 4: Provide therapeutic compression

Compression therapy is the gold standard of care for VLU management and has been shown to increase the rate of healing as compared to healing rates without the use of compression.¹

3M™ Coban™ 2 and

3M™ Coban™ 2 Lite Two-Layer Compression Systems

See Instructions for Use.

* Warnings and precautions: When using BlastX™ Antimicrobial Wound Gel, do not use alginate dressings.
**3M™ Tegaderm™ Silicone Foam can be used for wound management and as part of a comprehensive pressure injury prevention program.
***This is not an analgesic.

Caution: Federal Law (U.S.A.) restricts the device to sale by or on order of a licensed health care professional.


Close  
Leg Ulcer clinical photo

Simplifying Venous Leg Ulcer Management

Read VLU best practices from a panel of global experts.

DOWNLOAD YOUR COPY

Made to make a difference: 3M™ Coban™ 2 Two-Layer Compression Systems

The Coban 2 Two-layer compression system provides therapeutic compression which has been shown to reduce edema and pain and improve daily activities. Plus, because the bandages are low-profile and comfortable to wear, patients are more likely to wear them longer.⁸,

See the studies:

  • Venus Leg Ulcer healing rate

    Venus Leg Ulcer healing rate

    In two retrospective analyses, Coban 2 Two-Layer Compression System illustrated increased healing rates compared to two other compression systems. Curious to learn more?

  • Quality of life

    Quality of Life

    In a retrospective analysis, Coban 2 Two-Layer Compression showed better healing rates compared to multi-layer bandage systems. Curious to learn more?


Where Practice Meets Perspective

Whether it is developing a deeper understanding of the lymphatic system and edema or learning about venous leg ulcer best practices and compression therapy, these videos provide practical tips and education from global thought leaders in advanced wound care.


3M Health Care Academy

Get free continuing education and deepen your understanding of VLUs/Compression Therapy.

Filter by:
Sort by:
Tags
Tags
Load More

References

    1. O’Meara S, Cullum N, Nelson EA, Dumville JC. Compression for venous leg ulcers. Cochrane Database Syst Rev. 2012
    2. Rice JB, Desai U, Cummings AKG, Birnbaum HG, Skornicki M, et al. (2014). Burden of venous leg ulcers in the United States. Journal of medical economics, 17(5), 347–356.
    3. Finlayson K, et al. Predicting the likelihood of venous leg recurrence: The diagnostic accuracy of a newly developed risk assessment tool. Int Wound. 2018: 1–9.
    4. Weller C, Buchbinder R, Johnston R. Interventions for helping people adhere to compression treatments for venous
    5. James GA, Swogger E, Wolcott R, et al. Biofilms in chronic wounds. Wound Repair Regen. 2008; 16:37–44.
    6. Attinger C, Wolcott R. Clinically addressing biofilm in chronic wounds. Adv Wound Care. 2012. 1, 127–132.
    7. M Romanelli, K Vowden, D Weir. Exudate Management Made Easy. Wounds International 2010: 1(2): Available from http://www.woundsinternational.com
    8. Mosti G, Crespi A, Mattaliano V. Comparison Between a new, Two-component Compression System with Zinc Paste Bandages for Leg Ulcers Healing: A Prospective, Multicenter, Randomized, Controlled Trail Monitoring Sub-bandage Pressures. Wounds. 2011;23(5):126–134.
    9. Moffatt C, Edwards L, Collier M, Treadwell T, Miller M, Shafer L, Sibbald RG, Brassard A, McIntosh A, Reyzelman A, Price P, Krause SM, Walters SA, Harding K. A randomized controlled 8-week crossover clinical evaluation of the 3M™ Coban™ 2 Layer Compression System versus Profore™ to evaluate product performance in patients with venous leg ulcers. Int Wound J. 2008;5(2);267–279.

    * Warnings and precautions: When using BlastX™ Antimicrobial Wound Gel, do not use alginate dressings.

    **3M™ Tegaderm™ Silicone Foam can be used for wound management and as part of a comprehensive pressure injury prevention program.

    ***This is not an analgesic.

    †Caution: Federal Law (U.S.A.) restricts the device to sale by or on order of a licensed health care professional.

Follow Us
Change Location
United States - English